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Abstract 
 
Background: Oral Lichen planus (OLP) is a chronic lesion of the oral mucosa with unknown origin. Basement 
membrane changes are common in OLP and may be mediated by proteases such as matrix metalloproteinase 
(MMPs) and mast cell chymase. The aim of our study was to evaluate the level of serum MMP-3 in OLP com-
pared to normal individuals and assess its clinical significance. 
 
Methods: Thirty four serum samples from patients diagnosed with OLP (12 males, 22 females, age: 42.2±10.8 
years) and 34 serum samples from healthy control subjects (11 males, 23 females, age: 42.5±13.3 years) were 
collected and MMP-3 concentration was measured by ELISA. 
 
Results: The serum MMP-3 level in OLP patients was higher (21.64±24.31 ng/ml) compared with healthy con-
trols (16.52±23.63 ng/ml), but showed no statistically significant difference. A statistically significant difference 
was demonstrated between the two types of OLP, being more pronounced in the erosive/atrophic form 6). 
 
Conclusion: The different clinical appearances of OLP are associated with significant differences in MMP-3 
serum level. 
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Introduction 
 
Oral Lichen planus (OLP) is a chronic lesion of the oral 
mucosa, with a prevalence of 0.1% to 4%.
1 Clinically, 
OLP has a distinct morphology with two typical forms: 
atrophic-erosive lesions with or without concomitant 
reticular lesions, and reticular and/or plaque lesions.
2 
The cause of Lichen planus is unknown, but it is 
likely that both endogenous genetic and exogenous 
environmental components such as drugs or infec-
tions may interact to elicit the disease. Cell-mediated 
immunity plays the major role in triggering the clini-
cal expression of the disease.
3-5 
Basement membrane (BM) changes are common 
in OLP and comprise breaks, branches and duplica-
tions. BM damage in OLP may be mediated by prote-
ases such as matrix metalloproteinase (MMPs) and 
mast cell chymase.
6 
MMPs are a large family of zinc-dependent endo-
peptidases, which are capable of digesting extracellu-
lar matrix and BM component.
7 MMPs generally con-
sist of a prodomain, a catalytic domain, a hinge re-
gion, and a hemopexin domain. They are either se-
creted from the cell or anchored to the plasma mem-
brane. On the basis of substrate specificity, sequence 
similarity, and domain organization, vertebrate 
MMPs are divided into six groups: collagenases, 
gelatinases, stromelysins, matrilysins, membrane-type 
MMPs and others.
8 
MMP-3 is a stromelysin which degrades many non-
collagenous matrix components such as proteoglycans, 
fibronectin, laminin and gelatin in addition to type III , 
IV and V collagen and also activates interstitial procol-
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lagenase (proMMP-1) and progelatinase B (proMMP-
9).
9 A number of metalloproteinases have been identi-
fied in blood serum that are categorized mainly in four 
groups: a) collagenases (MMP-1, MMP-8, MMP-13, 
MMP-18), b) gelatinases (MMP-2, MMP-9), c) 
stromelysins (MMP-3, MMP-10) and d) membrane-
bound metalloproteinases (MMP-14, MMP-15, MMP-
16, MMP-17, MMP-24, MMP-25).
10 
Previous studies using immunohistochemistry 
showed that MMP-2 and MMP-3 were mainly found 
in OLP epithelium, but no one has elucidated the cir-
culating serum level of MMP-3 in OLP. Therefore, 
the aim of our study was to evaluate the level of se-
rum MMP-3 in OLP compared to normal individuals 
and assess its clinical significance.  
 
 
Materials and Methods 
 
For the purpose of this study, 34 serum samples from 
patients diagnosed with OLP (12 males, 22 females, 
age: 42.2±10.8 years) and 34 serum samples from 
healthy control subjects (11 males, 23 females, age: 
42.5±13.3 years) were collected. All the study patients 
were admitted to Oral Medicine Department of Shiraz 
University of Medical Sciences and OLP was diagnosed 
clinically and histopathologically in all of these patients. 
Control cases were healthy blood donors, who 
were matched for age and sex. Exclusion criteria in-
cluded the presence of any systemic disease, use of 
corticosteroid or non-steroid anti-inflammatory medi-
cation, or a history of chronic pulmonary disease or 
malignancy of any type. All participants were in-
formed about the research study and agreed to partic-
ipate by signing an informed consent form. The types 
of OLP were subclassified into two clinical forms: 
reticular and/or plaque lesions (25 cases) and ero-
sive/atrophic lesions (9 cases). 
Serum samples were obtained from clotted blood 
following centrifugation at 4°C and stored at -80°C 
until analysis. MMP-3 concentrations were measured 
by ELISA in accordance with the manufacturer’s in-
structions (BMS2014/2 BenderMed Systems GmbH, 
Germany). Statistical analysis was performed by us-
ing Mann-Whitney and Chi-Square tests. A p value 
less than 0.05 was considered significant. 
 
 
Results 
 
Histologic examination of all OLP specimens showed 
typical findings of this disease, including a band-like, 
mainly lymphocytic infiltrate in the connective tissue 
adjacent to the epithelial basement membrane, lique-
faction degeneration of the basement membrane, and 
destruction of basal keratinocytes. There were 22 
(64.7%) females and 12 (35.3%) males diagnosed 
with OLP in our study. 
The serum MMP-3 level in OLP patients was 
higher (21.6±24.3 ng/ml) compared with healthy con-
trols (13.5±17.9 ng/ml), but showed no statistically 
significant difference (p=0.227). 
After adjustment for sex, a statistically significant 
difference was demonstrated between the two types of 
OLP, being more pronounced in the erosive/atrophic 
form, correlating with the severity of this malady   
(Table 1, p<0.001). The serum level of MMP-3 was 
statistically higher in male patients (28.0±23.2 ng/ml) 
than in females (12.2±18.8 ng/ml, p<0.001). 
 
Table 1: Serum level of MMP-3 in different groups
Group  Number   Level of MMP-3 
(ng/ml)
a 
Control   34  13.5±17.9 
Reticular OLP  25  9.9±12.3 
Erosive OLP 9 49.8±23.2
a The difference of mean MMP-3 between control and 
reticular OLP were not significance but mean MMP-3 
in erosive OLP dramatically was higher than other 
groups (p<0.001). 
 
 
Discussion 
 
The pathogenesis of OLP features a complex series of 
interactions between inflammatory cells, chemokines 
and cytokines that ultimately determine the apoptosis 
of basal keratinocytes, triggered by the contacts be-
tween CD8
+- activated lymphocytes and an unknown 
antigen expressed on the surface of basal cells.
11,12 
BM degradation, which allows lymphocytes to mi-
grate, involves proteolytic enzymes called MMPs.
6,13 
MMPs involved in cell migration, angiogenesis and 
proteolytic activation of growth factors, events need-
ed in normal tissue remodeling as well as wound 
healing and tumor invasion.
14 The first study investi-
gating the relation of LP and MMPs was by Giannelli 
et al.,
15 They reported increased MMP-2 expression 
in acute stages of LP and suggested that an altered 
balance between MMP-2 and TIMP-2 may play a role 
in the destruction of BM. In 1998, the results of a 
study comparing OLP, dysplasia and squamous cell Farzin et al. 
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carcinoma (SCC) revealed that MMP-1, MMP-2, and 
MMP-3 expression were lower in OLP than SCC, and 
MMPs and TIMPs were clearly upregulated during 
invasion in oral SCC.
16 
Later, Zhou et al. reported MMP-2 and MMP-3 
expression in OLP epithelium and increased MMP-9 
expression in the inflammatory infiltrate cells. They 
suggested that MMPs may act synergistically to de-
grade the epithelial BM in OLP.
5 Kim et al. reported 
that under upregulation by bone morphogenetic pro-
tein BMP-4, both MMP-1 and MMP-3 expression in 
OLP may induce epithelial cells acantholysis and lead 
to erosive changes.
17 
Mazzarella et al. showed that the overall levels of 
expression of MMP mRNAs were higher in erosive 
OLP than in the reticular form. Moreover, MMP-1 
and MMP-3 may be principally associated with ero-
sion development.
18 Tsai et al. were the first who elu-
cidated the circulating plasma expression of MMPs in 
OLP.
19 They reported that MMP-2 overexpression in 
OLP is consistent with its upregulation in peripheral 
serum. In the present study we showed that serum 
level of MMP3 was not significantly higher than 
healthy controls.  
Furthermore, serum MMP-3 levels tended to 
change with the switching of the clinical subtypes of 
OLP, particularly increasing in the erosive/atrophic of 
the disease. MMP families can do the breakdown of 
intercellular bridge and acantolysis.
17 Our results 
suggested that MMP-3 seems to play a key role in the 
transformation of reticular to erosive form, possibly 
by inducing acantholysis and the low level of MMP3 
in reticular OLP could therefore explain the absence 
of erosions in this clinical form. 
Our findings was in accordance with Mazzarella et 
al. which reported that expression of MMP-3 mRNAs 
were higher in erosive Lichen planus than in the re-
ticular form. A permanent or prolonged presence of 
high MMP-3 amounts in serum may contribute to 
malignant transformation of OLP lesions, It is known 
that MMP-3 has a role in oncogenesis and expressed 
in OSCC,
20,21 as well as that the erosive/atrophic form 
of OLP has a greater rate of malignant evolution in 
comparison with the reticular form.
22 
In our study there were statistically significant dif-
ferences between male and female patients in terms of 
the serum MMP-3 levels. Probably, this difference 
was due to the fact that erosive form was more com-
mon in males than females in this study. In conclu-
sion we showed that the different clinical appearances 
of OLP were associated with significant differences 
in MMP-3 serum level. 
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